FDA Panel Rejects Widespread Pfizer Booster Shots

Scientists and government officials have been divided over the issue.

On Friday, a panel of scientists with the Food and Drug Administration rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans. Their 16-2 vote runs counter to President Biden’s announced plan to offer boosters beginning the week of September 20.

The FDA Vaccine and Related Biological Products Advisory Committee invited outside experts and expressed frustration that Pfizer had provided little data on the safety of extra doses. The panel said that data provided by Israeli researchers about their booster campaign might not be suitable for predicting the U.S. experience.

Scientists, as well as officials in the government, have been divided in recent days over the need for boosters and who should get them. 

As the Lord Leads, Pray with Us…

  • For the FDA officials who are assessing the benefits of therapeutics and treatments for the virus.
  • For the CDC and NIH as data is reviewed regarding the level of immunity provided by the vaccine versus those who have recovered from COVID.

Sources: CBS News, Fox News, Newsmax


Back to top